Drug
Norfloxacin clinical trials
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
5 studies that test it; most in 2000 (1)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2018 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 6
Tanta University (1) · Unity Health Toronto (1) · Hospital Clinic of Barcelona (1) · Assistance Publique - Hôpitaux de Paris (1) · OBS Pakistan (1) · Govind Ballabh Pant Hospital (1) · Bayside Health (1)
Often tested with
Tested in the same studies.
Nitazoxanide (1) · Colistin (1) · Propranolol (1) · VSL#3 (1)
Studies
Open first, then newest update. How each study uses Norfloxacin is read from its arms, and is right about nine times in ten.
Testing it · 7
- Comparative Study of Secondary Prophylaxis for SBPCompletedPhase 4Tanta UniversityNCT06827756Written as Norfloxacin 400 MG
- Noroxin Efficacy and Safety TrialStatus unknownPhase 4OBS PakistanNCT03506256Written as Norfloxacin 400 MG
- A Pilot Study of Norfloxacin for Hepatopulmonary SyndromeCompletedPhase 2Unity Health TorontoNCT00362752Written as Norfloxacin
- Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver FailureTerminatedPhase 3Assistance Publique - Hôpitaux de ParisNCT01037959Written as Norfloxacin
- Probiotics for Portal HypertensionStatus unknownPhase 3Govind Ballabh Pant HospitalNCT01134692Written as Propranolol, Norfloxacin, VSL#3
- Vasoactive Peptides in Portal PressureStatus unknownNot applicableBayside HealthNCT00163982Written as Norfloxacin
- Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial PeritonitisCompletedPhase 4Hospital Clinic of BarcelonaNCT00359853Written as Oral norfloxacin
Given in every arm · 3 — Norfloxacin is usual care beside what is tested
- Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial PeritonitisRecruitingPhase 3Tanta UniversityNCT04161768Written as Norfloxacin
- Nitazoxanide in Prevention of Secondary Spontaneous PeritonitisStatus unknownPhase 3Tanta UniversityNCT04746937Written as Norfloxacin
- Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial PeritonitisCompletedNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT03702426Written as Norfloxacin
As the comparator · 6 — what is tested is compared with Norfloxacin
- Efficacy of Rifaximin vs Norfloxacin for Secondary Prophylaxis of SBP (NORRIF Trial)Not yet recruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT06199843Written as Norfloxacin
- Rifaximin Versus Norfloxacin in Spontaneous Bacterial PeritonitisStatus unknownPhase 3Ospedali Riuniti di FoggiaNCT04159870Written as Norfloxacin
- Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial PeritonitisStatus unknownPhase 3Sherief Abd-ElsalamNCT02120196Written as Norfloxacin
- Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) PreventionCompletedPhase 4Korea UniversityNCT01542801Written as Norfloxacin
- Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)WithdrawnPhase 3Eurofarma Laboratorios S.A.NCT01527019Written as Norfloxacin
- Symptomatic Therapy of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting.TerminatedPhase 4Insel Gruppe AG, University Hospital BernNCT01039545Written as Norfloxacin
Codes
What other systems call Norfloxacin · ClinicalTrials.gg INT007909
- MeSH (NLM) D009643NorfloxacinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) N0F8P22L1PNORFLOXACINConfirmed FDA, NLM, Wikidata
- RxNorm 7517Confirmed FDA, Wikidata
- Wikidata Q417897norfloxacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47638NorfloxacinOne source FDA
- DrugBank DB01059One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009643 | Norfloxacin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | N0F8P22L1P | NORFLOXACIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 7517 | — | Confirmed FDA, Wikidata |
| Wikidata | Q417897 | norfloxacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47638 | Norfloxacin | One source FDA |
| DrugBank | DB01059 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.